Acquisitions of manufacturing plants in Jiangsu Prov. and Shandong Prov, China
Patent approval for AGC drug processing
Vanworld opens its new headquarters in Hong Kong
Acquisition of patented drug: RNA+Heparin compound formulation
GMP accreddited clinical trials of AGC in 3 Grade A hospitals in Beijing
SFDA approval of new AGC drug license
Awarded production license and launch of AGC ampoule
Granted patent for intermediate material 'inflamed rabbit skin'
Awarded as a "New Advanced Technology Product"
SFDA approval of symptomatic neuralgia indication
Filing of optimized AGC dosage based on new research insights